Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2020 $ 43 $ 46,366 $ (90,180) $ (43,771)
Beginning balance (in shares) at Dec. 31, 2020 42,973,462      
Common stock issued   6,927   6,927
Common stock issued (in shares) 333,121      
Reclassification of settlement liability upon issuance of warrant   60,852   60,852
Stock-based compensation   372   372
Net income (loss) - basic     (25,489) (25,489)
Ending balance at Mar. 31, 2021 $ 44 122,016 (115,669) 6,391
Ending balance (in shares) at Mar. 31, 2021 44,802,799      
Beginning balance at Dec. 31, 2020 $ 43 46,366 (90,180) $ (43,771)
Beginning balance (in shares) at Dec. 31, 2020 42,973,462      
Common stock and warrants issued in private placement, net of issuance costs (in shares)       3,642,515
Common stock issued for consulting services (in shares)       834,045
Proceeds from issuance of common stock for exercise of warrant (in shares)       3,830,586
Net income (loss) - basic       $ (62,656)
Ending balance at Sep. 30, 2021 $ 55 161,262 (152,835) 8,482
Ending balance (in shares) at Sep. 30, 2021 54,810,338      
Beginning balance at Dec. 31, 2020 $ 43 46,366 (90,180) (43,771)
Beginning balance (in shares) at Dec. 31, 2020 42,973,462      
Ending balance at Dec. 31, 2021 $ 59 203,990 (183,243) 20,806
Ending balance (in shares) at Dec. 31, 2021 58,810,550      
Beginning balance at Mar. 31, 2021 $ 44 122,016 (115,669) 6,391
Beginning balance (in shares) at Mar. 31, 2021 44,802,799      
Common stock issued   1,562   1,562
Common stock issued (in shares) 71,056      
Effect of Merger and recapitalization, net of redemptions and issuance costs $ 4 (64,840)   (64,836)
Effect of Merger and recapitalization, net of redemptions and issuance costs (in shares) 2,529,730      
Common stock issued pursuant to PIPE financing, net of issuance costs $ 1 8,099   8,100
Common stock issued pursuant to PIPE financing, net of issuance costs (in shares) 1,000,000      
Common stock issued for advisor services   4,850   4,850
Common stock issued for advisor services (in shares) 200,000      
Modification of option awards pursuant to Merger   1,014   1,014
Modification of warrants pursuant to Merger   2,331   2,331
Stock-based compensation   938   938
Net income (loss) - basic     (117) (117)
Ending balance at Jun. 30, 2021 $ 49 75,970 (115,786) (39,767)
Ending balance (in shares) at Jun. 30, 2021 48,603,585      
Common stock and warrants issued in private placement, net of issuance costs $ 3 27,356   $ 27,359
Common stock and warrants issued in private placement, net of issuance costs (in shares) 2,727,273     3,238,338
Common stock issued   1,134   $ 1,134
Common stock issued (in shares) 511,065      
Common stock issued for consulting services $ 1 7,925   $ 7,926
Common stock issued for consulting services (in shares) 634,045     634,045
Proceeds from issuance of common stock for exercise of warrant $ 2 47,317   $ 47,319
Proceeds from issuance of common stock for exercise of warrant (in shares) 2,334,370     2,334,370
Stock-based compensation   1,560   $ 1,560
Net income (loss) - basic     (37,049) (37,049)
Ending balance at Sep. 30, 2021 $ 55 161,262 (152,835) 8,482
Ending balance (in shares) at Sep. 30, 2021 54,810,338      
Beginning balance at Dec. 31, 2021 $ 59 203,990 (183,243) 20,806
Beginning balance (in shares) at Dec. 31, 2021 58,810,550      
Common stock and warrants issued in private placement, net of issuance costs $ 8 22,972   22,980
Common stock and warrants issued in private placement, net of issuance costs (in shares) 7,824,727      
Common stock issued for consulting services   17   17
Common stock issued for consulting services (in shares) 6,037      
Stock-based compensation   1,334   1,334
Net income (loss) - basic     (13,448) (13,448)
Ending balance at Mar. 31, 2022 $ 67 228,313 (196,691) 31,689
Ending balance (in shares) at Mar. 31, 2022 66,641,314      
Beginning balance at Dec. 31, 2021 $ 59 203,990 (183,243) $ 20,806
Beginning balance (in shares) at Dec. 31, 2021 58,810,550      
Common stock and warrants issued in private placement, net of issuance costs (in shares)       7,824,727
Net income (loss) - basic       $ (29,513)
Ending balance at Sep. 30, 2022 $ 68 229,470 (212,756) 16,782
Ending balance (in shares) at Sep. 30, 2022 67,641,314      
Beginning balance at Mar. 31, 2022 $ 67 228,313 (196,691) 31,689
Beginning balance (in shares) at Mar. 31, 2022 66,641,314      
Additional issuance costs in connection with Private Placement   (342)   (342)
Stock-based compensation   987   987
Net income (loss) - basic     (6,982) (6,982)
Ending balance at Jun. 30, 2022 $ 67 228,958 (203,673) 25,352
Ending balance (in shares) at Jun. 30, 2022 66,641,314      
Restricted stock awards granted $ 1 (1)    
Restricted stock awards granted (in shares) 1,000,000      
Additional issuance costs in connection with Private Placement   (28)   (28)
Stock-based compensation   541   541
Net income (loss) - basic     (9,083) (9,083)
Ending balance at Sep. 30, 2022 $ 68 $ 229,470 $ (212,756) $ 16,782
Ending balance (in shares) at Sep. 30, 2022 67,641,314